[1. L. Zhang and S. Mao, Application of quality by design in the current drug development, As. J. Pharm. Sci. 12 (2017) 1–8; https://doi.org/10.1016/j.ajps.2016.07.00610.1016/j.ajps.2016.07.006703218332104308]Search in Google Scholar
[2. M. R. Prausnitz and R. Langer, Transdermal drug delivery, Nat. Biotechnol. 26 (2008) 1261–1268; https://doi.org/10.1038/nbt.150410.1038/nbt.1504270078518997767]Search in Google Scholar
[3. M. J. Tsai, I. J. Lu, Y. S. Fu, Y.P. Fang, Y. B. Huang and P. C. Wu, Nanocarriers enhance the transdermal bioavailability of resveratrol: In-vitro and in-vivo study, Colloids Surf. B Biointerfaces148 (2016) 650–656; https://doi.org/10.1016/j.colsurfb.2016.09.04510.1016/j.colsurfb.2016.09.04527697739]Search in Google Scholar
[4. A. Simon and M. I. Amaro, A. M. Healy, L. M. Cabral and V. P. de Sousa, Comparative evaluation of rivastigmine permeation from a transdermal system in the Franz cell using synthetic membranes and pig ear skin with in vivo-in vitro correlation, Int. J. Pharm. 512 (2016) 234–241; https://doi.org/10.1016/j.ijpharm.2016.08.05210.1016/j.ijpharm.2016.08.05227568498]Search in Google Scholar
[5. E. M. Pridgen, F. Alexis and O. C. Farokhzad, Polymeric nanoparticle drug delivery technologies for oral delivery applications, Expert Opin. Drug. Deliv. 12 (2015) 1459–1473; https://doi.org/10.1517/17425247.2015.101817510.1517/17425247.2015.1018175483517325813361]Search in Google Scholar
[6. M. Arafat, Approaches to achieve an oral controlled release drug delivery system using polymers: a recent review, Int. J. Pharm. Pharm. Sci. 7 (2015) 16–21.]Search in Google Scholar
[7. R. Gannu, Y. V. Vishnu, V. Kishan and Y. M. Rao, Development of nitrendipine transdermal patches: in vitro and ex vivo characterization, Curr. Drug Deliv. 4 (2007) 69–76.10.2174/15672010777931476717269919]Search in Google Scholar
[8. M. Arafat, Bilosomes as a Drug Delivery System, in Thesis, Doctor of Philosophy, University of Otago, NZ, (2012); http://hdl.handle.net/10523/2157]Search in Google Scholar
[9. M. N. Pastore, Y. N. Kalia, M. Horstmann and M. S Roberts, Transdermal patches: history, development and pharmacology, Br. J. Pharmacol. 172 (2015) 2179–2209; https://doi.org/10.1111/bph.1305910.1111/bph.13059440308725560046]Search in Google Scholar
[10. M. B. Brown, G. P. Martin, S. A. Jones and F. K. Akomeah, Dermal and transdermal drug delivery systems: Current and future prospects, Drug Del. 13 (2008) 175–187; https://doi.org/10.1080/1071754050045597510.1080/1071754050045597516556569]Search in Google Scholar
[11. K. S. Paudel, M. Milewski, C. L. Swadley, N. K Brogden, P. Ghosh and A. L. Stinchcomb, Challenges and opportunities in dermal/transdermal delivery, Ther. Deliv. 1 (2010) 109–131.10.4155/tde.10.16299553021132122]Search in Google Scholar
[12. G. A. Van Norman, Drugs, Devices, and the FDA: Part 2: An overview of approval processes: FDA approval of medical devices, JACC: Bas. Transl. Sci. 1 (2016) 277–287; https://doi.org/10.1016/j.jacbts.2016.03.00910.1016/j.jacbts.2016.03.009611334030167516]Search in Google Scholar
[13. M. Isaac and C. Holvey, Transdermal patches: the emerging mode of drug delivery system in psychiatry, Ther. Adv. Psychopharmacol. 2 (2012) 255–263; https://doi.org/10.1177/204512531245831110.1177/2045125312458311373695223983984]Search in Google Scholar
[14. A. Z. Alkilani, M. T. C. McCrudden and R. F. Donnelly, Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum, Pharmaceutics7 (2015) 438–470; https://doi.org/10.3390/pharmaceutics704043810.3390/pharmaceutics7040438469582826506371]Search in Google Scholar
[15. M. Murphy and A. J. Carmichael, Transdermal drug delivery systems and skin sensitivity reactions. Incidence and management, Am. J. Clin. Dermatol. 1 (2000) 361–368.10.2165/00128071-200001060-0000411702612]Search in Google Scholar
[16. P. Karandea and S. Mitragotrib, Enhancement of transdermal drug delivery via synergistic action of chemicals, Biochim. Biophys. Acta1788 (2009) 2362–2373; https://doi.org/10.1016/j.bbamem.2009.08.01510.1016/j.bbamem.2009.08.01519733150]Search in Google Scholar
[17. J. Suksaeree, C. Monton, F. Madaka, T. Chusut, W. Saingam, W. Pichayakorn and P. Boonme, Formulation, physicochemical characterization, and in vitro study of chitosan/HPMC blends-based herbal blended patches, AAPS Pharm. Sci. Tech. 16 (2015) 171–181; https://doi.org/10.1208/s12249-014-0216-610.1208/s12249-014-0216-6430982125233803]Search in Google Scholar
[18. N. S. Chandrashekar and R. H. S. Rani, Physicochemical and pharmacokinetic parameters in drug selection and loading for transdermal drug delivery, Indian J. Pharm. Sci. 70 (2008) 94–96; https://doi.org/10.4103/0250-474X.4034010.4103/0250-474X.40340285207020390089]Search in Google Scholar
[19. M. Arafat, The effect of intestinal bile on the stability of lipid-based vesicular system used as oral drug carriers, Glob. Drug Therap. 2 (2016) 1–2; https://doi.org/10.15761/GDT.100010910.15761/GDT.1000109]Search in Google Scholar
[20. J. Suksaereeab, L. Charoenchaib, F. Madakab, C. Montonb, A. Sakunpak, T. Charoonratana and W. Zingiber, Cassumunar blended patches for skin application: Formulation, physicochemical properties, and in vitro studies, Asian J. Pharm. Sci. 10 (2015) 341–349; https://doi.org/10.1016/j.ajps.2015.03.00110.1016/j.ajps.2015.03.001]Search in Google Scholar
[21. A. C. Willams and B. W. Barry, Penetration enhancers, Adv. Drug. Del. Rev. 56 (2004) 603–618.10.1016/j.addr.2003.10.02515019749]Search in Google Scholar
[22. S. D. Saoji, S. C. Atram, P. W. Dhore, P. S. Deole, N. A. Raut and V. S. Dave, Influence of the component excipients on the quality and functionality of a transdermal film formulation, AAPS Pharm. Sci. Tech. 16 (2015) 1344–1356; https://doi:10.1208/s12249-015-0322-010.1208/s12249-015-0322-0466625525922089]Search in Google Scholar
[23. M. Imani, F. Lahooti-Fard, S. M. Taghizadeh and M Takrousta, Effect of adhesive layer thickness and drug loading on estradiol crystallization in a transdermal drug delivery system, AAPS Pharm. Sci. Tech. 11 (2010) 1268–1275; https://doi.org/10.1208/s12249-010-9494-910.1208/s12249-010-9494-9]Search in Google Scholar
[24. S. Dhiman, T. G. Singh and A. K. Rehni, Transdermal patches: A recent approach to new drug delivery system, Int. J. Pharm. Pharm. Sci. 3 (2011) 26–34.]Search in Google Scholar
[25. S. Rani, K. Saroha, N. Syan and P. Mathur, Transdermal patches a successful tool in transdermal drug delivery system: An overview, Der Pharm. Sinica2 (2011) 17–29.]Search in Google Scholar
[26. B. Berner and V. A. John, Pharmacokinetic characterization of transdermal delivery system, J. Clin. Pharmacol. 26 (1994) 121–134.10.2165/00003088-199426020-00005]Search in Google Scholar
[27. S. Mutalik and N. Udupa, Pharmacological evaluation of membrane-moderated transdermal system of glipizide, Clin. Exp. Pharmacol. Physiol. 33 (2006) 17-26.10.1111/j.1440-1681.2006.04318.x]Search in Google Scholar
[28. C. L. Stevenson, J. T. Jr. Santini and R. Langer, Reservoir-based drug delivery systems utilizing microtechnology, Adv. Drug Deliv. Rev. 64 (2012) 1590–1602; https://doi.org/10.1016/j.addr.2012.02.00510.1016/j.addr.2012.02.005]Search in Google Scholar
[29. P. J. Hughes, M. K. Freeman and T. M. Wensel, Appropriate use of transdermal drug delivery systems, J. Nurs. Edu. Pract. 3 (2013) 129–138.10.5430/jnep.v3n10p129]Search in Google Scholar
[30. S. Cherukuri, U. R. Batchu, K. Mandava, V. Cherukuri, K. R. Ganapuram, Formulation and evaluation of transdermal drug delivery of topiramate, Int. J. Pharm. Investig. 7 (2017) 10–17; https://doi.org/10.4103/jphi.JPHI_35_1610.4103/jphi.JPHI_35_16]Search in Google Scholar
[31. E. Abd, S. A. Yousef, M. N. Pastore, K. Telaprolu, Y. H. Mohammed, S. Namjoshi, J. E. Grice and M. S. Roberts, Skin models for the testing of transdermal drugs, Clin. Pharmacol. 8 (2016) 163–176; https://doi.org/10.2147/CPAA.S6478810.2147/CPAA.S64788]Search in Google Scholar
[32. A. Z. Alkilani, M. T. C. McCrudden and R. F. Donnelly, Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum, Pharmaceutics7 (2015) 438–470; https://doi.org/10.3390/pharmaceutics704043810.3390/pharmaceutics7040438]Search in Google Scholar
[33. H. Trommer and R. H. H. Neubert, Overcoming the stratum corneum: the modulation of skin penetration, Skin Pharmacol. Physiol. 19 (2006) 106–121; https://doi.org/10.1159/00009197810.1159/000091978]Search in Google Scholar
[34. S. S. Davis and L. Illum, Drug Delivery Systems for Challenging Molecules, Int. J. Pharm. 176 (1998) 1–8.10.1016/S0378-5173(98)00290-7]Search in Google Scholar
[35. A. Ahmed, N. Karki, R. Charde, M. Charde and B. Gandhare, Transdermal drug delivery systems: An overview, Int. J. Biomed. Adv. Res. 2 (2010) 38–56.10.7439/ijbar.v2i1.21]Search in Google Scholar
[36. S. R. W. Baker and J. Heller, Material Selection for Transdermal Delivery Systems, in Transdermal Drug Delivery: Developmental Issues and Research Initiatives (Eds. J. Hadgraft and R. H. Guys), Marcel Dekker, Inc., New York 1989, pp. 293–311.]Search in Google Scholar
[37. M. Guyot and F. Fawaz, Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol, Int. J. Pharm. 204 (2000) 171–182.10.1016/S0378-5173(00)00494-4]Search in Google Scholar
[38. Ł. Zimmer, R. Kasperek and E. Poleszak, Modern polymers in matrix tablets technology, Polim. Med. 44 (2014)189–196.]Search in Google Scholar
[39. M. Guyot and F. Fawaz, Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol, Int. J. Pharm. 204 (2000) 171–182.10.1016/S0378-5173(00)00494-4]Search in Google Scholar
[40. A. F. El-Kattan, C. S. Asbill and B. B. Michniak, The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems, Int. J. Pharm. 198 (2000) 179–189.10.1016/S0378-5173(00)00330-6]Search in Google Scholar
[41. R. Sutinen, P. Paronen, V. Saano and A. Urtti, Water-activated, pH-controlled patch in transdermal administration of timolol: II. Drug absorption and skin irritation, Eur. J. Pharm. Sci. 11 (2000) 25–31.10.1016/S0928-0987(00)00083-X]Search in Google Scholar
[42. H. Iwase, J. I. Sudo, J. Terui, K. Kakuno, T. Watanabe, K. Takayama and T. Nagai, Transdermal absorption of L-dopa from a new system composed of two separate layers of L-dopa and hydrogel in rats, Drug Dev. Ind. Pharm. 26 (2000) 755–759.10.1081/DDC-100101294]Search in Google Scholar
[43. M. K. Kim, H. Zhao, C. H. Lee and D. D. Kim, Formulation of a reservoir-type testosterone trans-dermal delivery system, Int. J. Pharm. 219 (2001) 51–59.10.1016/S0378-5173(01)00631-7]Search in Google Scholar
[44. H. Gabiga, K. Cal and S. Janicki, Effect of penetration enhancers on isosorbide dinitrate penetration through rat skin from a transdermal therapeutic system, Int. J. Pharm. 199 (2000) 1–6.10.1016/S0378-5173(99)00363-4]Search in Google Scholar
[45. S. Ohmori, T. Hayash, M. Kawase, S. Saito, K. Sugibayashi and Y. Morimoto, Transdermal delivery of the potent analgesic dihydroetorphine: kinetic analysis of skin permeation and analgesic effect in the hairless rat, J. Pharm. Pharmacol. 52 (2000) 1437–1449.10.1211/0022357001777649]Search in Google Scholar
[46. T. Pongjanyakul, S. Prakongpan and A. Priprem, Permeation studies comparing cobra skin with human skin using nicotine transdermal patches, Drug Dev. Ind. Pharm. 26 (2000) 635–642.10.1081/DDC-10010127810826111]Search in Google Scholar
[47. S. M. Al-Saidan,Y. S. R. Krishnaiah, D. V. Chandrasekhar, J. K. Lalla, B. Rama, B. Jayaram and P. Bhaskar, Formulation of an HPMC gel drug reservoir system with ethanol-water as a solvent system and limonene as a penetration enhancer for enhancing in vitro transdermal delivery of nicorandil, Skin Pharmacol. Physiol. 17 (2004) 310–320.10.1159/00008111715528962]Search in Google Scholar
[48. Y. S. Krishnaiah, P. Bhaskar and V. Satyanarayana, Penetration-enhancing effect of ethanol-water solvent system and ethanolic solution of carvone on transdermal permeability of nimodipine from HPMC gel across rat abdominal skin, Pharm. Dev. Technol. 9 (2004) 63–74.10.1081/PDT-12002741915000467]Search in Google Scholar
[49. Y. Tanwar, C. Chauhan and A. Sharma, Development and evaluation of carvedilol transdermal patches, Acta Pharm. 57 (2007) 151–159.10.2478/v10007-007-0012-x17507312]Search in Google Scholar
[50. A. Wahid, B. Sridhar and S. Shivakumar, Preparation and evaluation of transdermal drug delivery system of etoricoxib using modified chitosan, Indian J. Pharm. Sci. 70 (2008) 455–460.10.4103/0250-474X.44593279253720046770]Search in Google Scholar
[51. B. Winblad and J. C. Machado. Use of rivastigmine transdermal patch in the treatment of Alzheimer’s disease, Expert Opin. Drug Deliv. 5 (2008) 1377–1386.10.1517/17425240802542690]Search in Google Scholar
[52. C. Ren, L. Fang, L. Ling, Q. Wang, S. Liu, L. Zhao and Z. He, Design and in vivo evaluation of an indapamide transdermal patch, Int. J. Pharm. 370 (2009) 129–135.10.1016/j.ijpharm.2008.12.004]Search in Google Scholar
[53. S. Jayaprakash, S. M. Halith, P. M. Firthouse and N. M. Yasmin, Preparation and evaluation of celecoxib transdermal patches, Pak. J. Pharm. Sci. 23 (2010) 279–283.]Search in Google Scholar
[54. Y. C. Ah, J. K. Choi, Y. K. Choi, H. M. Ki and J. H. Bae, A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization, Int. J. Pharm. 385 (2010) 12–19.10.1016/j.ijpharm.2009.10.013]Search in Google Scholar
[55. P. Anitha, S. Ramkanth, M. T. Saleem, K. Umasankari, B. P. Reddy and M. Chetty, Preparation, in-vitro and in-vivo characterization of transdermal patch containing glibenclamide and atenolol: a combinational approach, Pak. J. Pharm. Sci. 24 (2011) 155–163.]Search in Google Scholar
[56. D. M. Panchaxari, S. Pampana, T. Pal, B. Devabhaktuni and A. K. Aravapalli, Design and characterization of diclofenac diethylamine transdermal patch using silicone and acrylic adhesives combination, Daru21 (2013) 6; https://doi.org/10.1186/2008-2231-21-610.1186/2008-2231-21-6]Search in Google Scholar
[57. H. M. Wolff, Optimal process design for the manufacture of transdermal drug delivery systems, Pharm. Sci. Technol. Today. 3 (2000) 173–181.10.1016/S1461-5347(00)00251-0]Search in Google Scholar
[58. L. Bromberg, Crosslinked poly(ethylene glycol) networks as reservoirs for protein delivery, J. Appl. Polym. Sci. 59 (1996) 459–466.10.1002/(SICI)1097-4628(19960118)59:3<459::AID-APP10>3.0.CO;2-P]Search in Google Scholar
[59. P. Costa, D. C. Ferreira, R. Morgado and J. S. Lobo, Design and evaluation of a lorazepam transdermal delivery system, Drug Dev. Ind. Pharm. 23 (1997) 939–944.10.3109/03639049709149144]Search in Google Scholar
[60. P. Minghetti, F. Cilurzo and L. Montanari, Evaluation of adhesive properties of patches based on acrylic matrices, Drug Dev. Ind. Pharm. 25 (1999) 1–6.10.1081/DDC-100102135]Search in Google Scholar
[61. P. R. Rao and P. V. Diwan, Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration, Drug Dev. Ind. Pharm. 24 (1998) 327–336.10.3109/03639049809085627]Search in Google Scholar
[62. S. S. Baek and S. H. Hwang, Eco-friendly UV-curable pressure sensitive adhesives containing acryloyl derivatives of monosaccharides and their adhesive performances, Int. J. Adhes. Adhes. 70 (2016) 110–116; https://doi.org/10.1016/j.ijadhadh.2016.06.00210.1016/j.ijadhadh.2016.06.002]Search in Google Scholar
[63. S. Banerjee, P. Chattopadhyay, A. Ghosh, P. Datta and V. Veer, Aspect of adhesives in transdermal drug delivery systems, Int. J. Adhes. Adhes. 50 (2014) 70–84; https://doi.org/10.1016/j.ijadhadh.2014.01.00110.1016/j.ijadhadh.2014.01.001]Search in Google Scholar
[64. C. Fang, Y. Jing, Y. Zong and Z. Lin, Effect of N,N-dimethylacrylamide (DMA) on the comprehensive properties of acrylic latex pressure sensitive adhesives, Int. J. Adhes. Adhes. 71 (2016) 105–111; https://doi.org/10.1016/j.ijadhadh.2016.09.00310.1016/j.ijadhadh.2016.09.003]Search in Google Scholar
[65. V. G. Kadajji and G. V. Betageri. Water soluble polymers for pharmaceutical applications, Polymers3 (2011) 1972–2009; https://doi.org/10.3390/polym304197210.3390/polym3041972]Search in Google Scholar
[66. I. Benedek, M. M. Feldstein, N. Willenbacher and O. V. Lebedeva, Polyisobutene-Based Pressure-Sensitive Adhesives. Technology of Pressure-Sensitive Adhesives and Products, CRC Press; 2008. p. 4-1-4-18.10.1201/9781420059410-4]Search in Google Scholar
[67. X. Tong, Q. Wang, H. X. Wang, X. H. Li, W. Wu and X. Y. Chey, Fabrication of pH sensitive amphiphilic hot-melt pressure sensitive adhesives for transdermal drug delivery system, Int. J. Adhes. Adhes. 48 (2014) 217–223; https://doi.org/10.1016/j.ijadhadh.2013.09.02510.1016/j.ijadhadh.2013.09.025]Search in Google Scholar
[68. D. J. Lyman and B. H. Loo, New synthetic membranes for dialysis. IV. A copolyether–urethane membrane system, J. Biomed. Mater. Res. 1 (1967) 17–26.10.1002/jbm.820010105]Search in Google Scholar
[69. V. Stannett, W. Koros, D. Paul, H. Lonsdale and R. Baker, Recent Advances in Membrane Science and Technology, in Advances in Polymer Sciences, Vol. 32, Chemistry, Springer Verlag, Berlin 1979, pp. 69–121.10.1007/3-540-09442-3_5]Search in Google Scholar
[70. D. G. Maillard-Salin, P. Becourt and G. Couarraze, Physical evaluation of a new patch made of a progestomimetic in a silicone matrix, Int. J. Pharm. 199 (2000) 29–38.10.1016/S0378-5173(00)00357-4]Search in Google Scholar
[71. D. G. Maillard-Salin, P. Becourt and G. Couarraze, A study of the adhesive-skin interface: correlation between adhesion and passage of a drug, Int. J. Pharm. 200 (2000) 121–126.10.1016/S0378-5173(00)00369-0]Search in Google Scholar
[72. C. D. Ebert, W. Heiber, R. Andriola and P. Williams, Development of a novel transdermal system design, J. Control. Release. 6 (1987) 107–111.10.1016/0168-3659(87)90068-X]Search in Google Scholar
[73. A. Flo, T. Cambras, A. Díez-Noguera and A. Calpena, Melatonin pharmacokinetics after transdermal administration changes according to the time of the day, Eur. J. Pharm. Sci. 96 (2017) 164–170; https://doi.org/10.1016/j.ejps.2016.09.02010.1016/j.ejps.2016.09.02027644893]Search in Google Scholar
[74. I. Som, K. Bhatia and M. Yasir, Status of surfactants as penetration enhancers in transdermal drug delivery, J. Pharm. Bioallied Sci. 4 (2012) 2–9; https://doi.org/10.4103/0975-7406.9272410.4103/0975-7406.92724328395222368393]Search in Google Scholar
[75. Y. Chen, P. Quan, X. Liu, M. Wang and L. Fang, Novel chemical permeation enhancers for transdermal drug delivery, Asian J. Pharm. Sci. 9 (2014) 51–64.10.1016/j.ajps.2014.01.001]Search in Google Scholar
[76. Q. D. Pham, S. Björklund, J. Engblom, D. Topgaard and E. Sparr, Chemical penetration enhancers in stratum corneum – Relation between molecular effects and barrier function, J. Control. Release232 (2016) 175–187; https://doi.org/10.1016/j.jconrel.2016.04.03010.1016/j.jconrel.2016.04.03027108613]Search in Google Scholar
[77. G. El Maghraby, A. C. Williams and B. Barry, Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes, Int. J. Pharm. 276 (2004) 143–161.10.1016/j.ijpharm.2004.02.02415113622]Search in Google Scholar
[78. M. Arafat, C. Kirchhoefer, M. Mikov, M. Sarfraz and R. Löbenberg, Nanosized liposomes containing bile salt: A vesicular nanocarrier for enhancing oral bioavailability of BCS class III drug, J. Pharm. Pharm. Sci. 20 (2017) 305–318; https://doi.org/10.18433/J3CK8810.18433/J3CK8828885915]Search in Google Scholar
[79. M. Arafat, C. Kirchhoefer and M. Mikov, Mixed micelles loaded with bile salt: an approach to enhance intestinal transport of the BCS class III drug cefotaxime in rats, Eur. J. Drug Metab. Pharmacokinet. 42 (2017) 635–645; https://doi.org/10.1007/s13318-016-0375-910.1007/s13318-016-0375-927686853]Search in Google Scholar
[80. T. E. G. K. Murthy and V. S. Kishore, Effect of casting solvent and polymer on permeability of propranolol hydrochloride through membrane controlled transdermal drug delivery system, Indian J. Pharm. Sci. 69 (2007) 646–650; https://doi.org/10.4103/0250-474X.3846910.4103/0250-474X.38469]Search in Google Scholar
[81. A. Alexander, S. Dwivedi, T. K. Giri, S. Saraf and D. K. Tripathi, Approaches for breaking the barriers of drug permeation through transdermal drug delivery, J. Control. Release164 (2012) 26–40; https://doi.org/10.1016/j.jconrel.2012.09.01710.1016/j.jconrel.2012.09.01723064010]Search in Google Scholar
[82. Guideline on quality of transdermal patches. European Medicines Agency, Committee for Medicinal Products for Human Use (2014) 1-27. EMA/CHMP/QWP/608924/2014]Search in Google Scholar
[83. H. Lim and S. W. Hoag, Plasticizer effects on physical–mechanical properties of solvent cast Soluplus® films, AAPS Pharm. Sci. Tech. 14 (2013) 903–910; https://doi.org/10.1208/s12249-013-9971-z10.1208/s12249-013-9971-z375516923689959]Search in Google Scholar
[84. M. Arafat, Z. Ahmed and O. Arafat, Comparison between generic drugs and brand name drugs from bioequivalence and thermoequivalence prospective, Int. J. Pharm. Pharm. Sci. 9 (2017) 1–4.10.22159/ijpps.2017v9i6.18735]Search in Google Scholar
[85. M. Bharkatiya, R. Nema and M. Bhatnagar, Designing and characterization of drug free patches for transdermal application, Int. J. Pharm. Sci. Drug Res. 2 (2012) 35–39.]Search in Google Scholar
[86. K. C. Garala, A. J. Shinde and P. H. Shah, Formulation and in-vitro characterization of monolithic matrix transdermal systems using HPMC/Eudragit S 100 polymer blends, Int. J. Pham. Pharm. Sci. 1 (2009) 108–120.]Search in Google Scholar
[87. J. M. Prosser, B. E. Jones and L. Nelson, Complications of oral exposure to fentanyl transdermal delivery system patches, J. Med. Toxicol. 6 (2010) 443–447.10.1007/s13181-010-0092-8355045420532845]Search in Google Scholar
[88. J. Singh, K. Tripathi and T. Sakya, Effect of penetration enhancers on the in vitro transport of ephedrine through rat skin and human epidermis from matrix based transdermal formulations, Drug Dev. Ind. Pharm. 19 (1993) 1623–1628.10.3109/03639049309069331]Search in Google Scholar
[89. N. Maftoona, H. S. Ramaswamy and M. Marcotte, Evaluation of factors affecting barrier, mechanical and optical properties of pectin-based films using response surface methodology, J. Food. Process Eng. 30 (2007) 539–563; https://doi.org/10.1111/j.1745-4530.2007.00123.x10.1111/j.1745-4530.2007.00123.x]Search in Google Scholar
[90. A. Singh and A. Bali, Formulation and characterization of transdermal patches for controlled delivery of duloxetine hydrochloride, J. Anal. Sci. Technol. 7 (2016) 25; https://doi.org/10.1186/s40543-016-0105-610.1186/s40543-016-0105-6]Search in Google Scholar
[91. J. Wiechers, Use of chemical penetration enhancers in transdermal drug delivery – possibilities and difficulties, Acta Pharm Nord. 4 (1992) 123.]Search in Google Scholar
[92. S. Banerjee, P. Chattopadhyay, A. Ghosh, P. Datta and V. Veer, Aspect of adhesives in transdermal drug delivery systems, Int. J. Adhes. Adhes. 50 (2014) 70–84.10.1016/j.ijadhadh.2014.01.001]Search in Google Scholar
[93. A. M. Wokovich, S. Prodduturi, W. H. Doub, A. S. Hussain and L. F. Buhse, Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute, Eur. J. Pharm. Biopharm. 64 (2006) 1–8.10.1016/j.ejpb.2006.03.009]Search in Google Scholar
[94. A. J. Steven-Fountain, A. G. Atkins, G. Jeronimidis, J. F. V. Vincent, D. F. Farrar and R. A. Chivers, The effect of flexible substrates on pressure-sensitive adhesive performance, Int. J. Adhes. Adhes. 22 (2002) 423–430.10.1016/S0143-7496(02)00018-0]Search in Google Scholar
[95. G. Thakur, A. Singh and I. Singh, Formulation and evaluation of transdermal composite films of chitosan-montmorillonite for the delivery of curcumin, Int. J. Pharm. Investig. 6 (2016) 23–31; https://doi.org/10.4103/2230-973X.17646810.4103/2230-973X.176468478705927014616]Search in Google Scholar
[96. T. Kamal, M. Sarfraz, M. Arafat, M. Mikov and N Rahman, Cross-linked guar gum and sodium borate based microspheres as colon-targeted anticancer drug delivery systems for 5-fluorouracil, Pak. J. Pharm. Sci. 30 (2017) 2329–2336.]Search in Google Scholar
[97. O. A. Hanbali, R. Hamed, M. Arafat, Y. Bakkour, H. Matubsi, R. Mansour, Y. Bataineh, M. Aldhoun, M. Sarfraz and A. K. Yousef Dardas, Formulation and evaluation of diclofenac controlled release matrix tablets made of HPMC and Poloxamer 188 polymer: An assessment on mechanism of drug release, Pak. J. Pharm. Sci. 31 (2018) 345–351.]Search in Google Scholar
[98. T. Z. Marques, R. Santos-Oliveira, L. B. de Siqueira, V. S. Cardoso, Z. M. de Freitas, R. C. Barros, A. L. Villa, M. S. Monteiro, E. P. Santos and E. Ricci-Junior, Development and characterization of a nanoemulsion containing propranolol for topical delivery, Int. J. Nanomedicine13 (2018) 2827–2837; https://doi.org/10.2147/IJN.S16440410.2147/IJN.S164404595706329785109]Search in Google Scholar
[99. C. S. Cerqueira-Coutinho, V. E. De Campo, A. L. Rossi, V. F. Veiga, C. Holandino, Z. M. Freitas, E. Ricci-Junior, C. R. Mansur, E. P. Santos and R. Santos-Oliveira, Comparing in vivo biodistribution with radiolabeling and Franz cell permeation assay to validate the efficacy of both methodologies in the evaluation of nanoemulsions: a safety approach, Nanotechnology27 (2016) 015101; https://doi.org/10.1088/0957-4484/27/1/01510110.1088/0957-4484/27/1/01510126605997]Search in Google Scholar
[100. J. Wang, Y. Wei, Y. R. Fei, L. Fang, H. S. Zheng, C. F. Mu, F. Z. Li and Y. S. Zhang, Preparation of mixed monoterpenes edge activated PEGylated transfersomes to improve the in vivo transdermal delivery efficiency of sinomenine hydrochloride, Int. J. Pharm. 533 (2017) 266–274; https://doi.org/10.1016/j.ijpharm.2017.09.05910.1016/j.ijpharm.2017.09.05928943208]Search in Google Scholar
[101. I. I. Abu Hashim, N. F. Abo El-Magd, A. R. El-Sheakh and M. F. Hamed, Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo–in vivo evaluation study, Int. J. Nanomedicine13 (2018) 1059–1079; https://doi.org/10.2147/IJN.S15641210.2147/IJN.S156412582475929503541]Search in Google Scholar
[102. A. Manosroi, C. Chankhampan, W. Manosroi and J. Manosroi, Transdermal absorption enhancement of papain loaded in elastic niosomes incorporated in gel for scar treatment, Eur. J. Pharm. Sci. 48 (2013) 474–483; https://doi.org/10.1016/j.ejps.2012.12.01010.1016/j.ejps.2012.12.01023266464]Search in Google Scholar